| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1f2ad27de8500a0344d268577be16e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83e8a7ffa0a55710f68251bda3a82458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_222f6e500f647299848d30601f8984c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05324dcb1cf1d20b8023b975d4cda4ac |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| filingDate |
2011-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ade999dd674cd55f475a6205a179583a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfaf1412bd57fddba181b21e3a5db01b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_103f62ae97d5ce61bc8178b4f55db7b3 |
| publicationDate |
2012-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012047813-A1 |
| titleOfInvention |
Macrocyclic lactone compounds and methods for their use |
| abstract |
The present disclosure provides a device for intracorporeal use which comprises an implant or a temporary device and at least one source of myolimus or a derivative thereof. The present disclosure also provides a method of inhibiting cell proliferation, inflammation or cytokine production by systemic or local administration of a therapeutically effective amount of myolimus or a derivative thereof. Further included in the present disclosure is a method of treating an ophthalmic condition or disease by administering a therapeutically effective amount of myolimus or a derivative thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654036-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014070322-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9060923-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9750627-B2 |
| priorityDate |
2010-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |